133 related articles for article (PubMed ID: 1656740)
1. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
Dark D
Am J Med; 1991 Sep; 91(3A):31S-35S. PubMed ID: 1656740
[TBL] [Abstract][Full Text] [Related]
2. Cefaclor in the treatment of infective exacerbations of chronic bronchitis in cigarette smokers.
Cazzola M; Franco C; Gioia V; Legnani D; Mancini V; Polverino M; Sevieri G
J Chemother; 1991 Aug; 3(4):245-9. PubMed ID: 1779259
[TBL] [Abstract][Full Text] [Related]
3. Cefaclor AF: correlation of microbiology and clinical outcome.
Thornsberry C
Postgrad Med J; 1992; 68 Suppl 3():S10-6. PubMed ID: 1287612
[TBL] [Abstract][Full Text] [Related]
4. A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
Hoepelman AI; Sips AP; van Helmond JL; van Barneveld PW; Neve AJ; Zwinkels M; Rozenberg-Arska M; Verhoef J
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():147-52. PubMed ID: 8396086
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis.
Casiano RR
Am J Med; 1991 Sep; 91(3A):27S-30S. PubMed ID: 1656739
[TBL] [Abstract][Full Text] [Related]
6. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis.
Grossman RF
Postgrad Med J; 1992; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.
Kinasewitz G; Wood RG
Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):872-7. PubMed ID: 1662636
[TBL] [Abstract][Full Text] [Related]
8. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
[TBL] [Abstract][Full Text] [Related]
9. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
Daniel R
J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-blind controlled trial of roxithromycin and cefaclor in the treatment of acute lower respiratory tract infections in general practice.
Tilyard MW; Dovey SM
Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):97S-101S. PubMed ID: 1617932
[TBL] [Abstract][Full Text] [Related]
11. Cefpodoxime proxetil suspension compared with cefaclor suspension for treatment of acute otitis media in paediatric patients.
MacLoughlin GJ; Barreto DG; de la Torre C; Pinetta EA; del Castillo F; Palma L
J Antimicrob Chemother; 1996 Mar; 37(3):565-73. PubMed ID: 9182113
[TBL] [Abstract][Full Text] [Related]
12. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
[TBL] [Abstract][Full Text] [Related]
13. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerance of erythromycin acistrate in the treatment of acute exacerbations of chronic bronchitis in the elderly.
Forsén KO; Wikberg R; Lehtonen L
Chemotherapy; 1993; 39(6):443-52. PubMed ID: 8222874
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute bronchitis and pneumonia with cefaclor.
Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
[TBL] [Abstract][Full Text] [Related]
16. Azithromycin. A review of its use in paediatric infectious diseases.
Langtry HD; Balfour JA
Drugs; 1998 Aug; 56(2):273-97. PubMed ID: 9711451
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Gotfried MH; Ellison WT
Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
[TBL] [Abstract][Full Text] [Related]
18. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections.
Mallory SB
Am J Med; 1991 Sep; 91(3A):36S-39S. PubMed ID: 1656741
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Cazzola M; Vinciguerra A; Di Perna F; Califano C; Calderaro F; Salzillo A; Centanni S
J Chemother; 1999 Apr; 11(2):119-25. PubMed ID: 10326742
[TBL] [Abstract][Full Text] [Related]
20. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
Alanis A; Longest KA; Senetar JE; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]